Clinical Trials Browser

Phase EARLY_PHASE1 × Neoplasm Metastasis × pembrolizumab × Clear all

NCT06308913 2026-05-26

Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma

Phase EARLY_PHASE1 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis

NCT02591654 2022-12-30

MPAK

Phase EARLY_PHASE1 Terminated

Melanoma, Neoplasm Metastasis